| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/05/2010 | CN101700260A Purslane seed polysaccharide granule preparation and preparation method thereof |
| 05/05/2010 | CN101700249A Pharmaceutical composition for preventing and treating rheumatoid arthritis |
| 05/05/2010 | CN101700247A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 05/05/2010 | CN101700245A Compound drug for curing colds and preparation technology thereof |
| 05/05/2010 | CN101700242A Steaming-based moxibustion patch |
| 05/05/2010 | CN101700239A Combined capsule filled with glycyrrhizin solid preparation and glycine solid preparation |
| 05/05/2010 | CN101031298B Medicine with analgesic function |
| 05/04/2010 | US7709669 Aspirin-triggered lipid mediators |
| 05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 05/04/2010 | US7709640 Inhibitors of phosphorylation of platelet derived growth factor receptor |
| 05/04/2010 | US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
| 05/04/2010 | US7709488 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-[4-(4-methylpiperazin-1-yl-sulfonyl)-phenyl]-3H-imidazo-[4,5-b]pyridine,; acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, organ transplantation and transplant rejection, head trauma, acute lung injury |
| 05/04/2010 | US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/04/2010 | US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter |
| 05/04/2010 | US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 05/04/2010 | US7709459 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 05/04/2010 | US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders |
| 05/04/2010 | US7709027 Bioactive glass comprising SiO2, Na2O, K2O, Li2O, CaO, MgO, Al2O3, P2O5, B2O3 and ZnO; free from silver, nontoxic; use in cosmetic, deodorants, medicinal products, paper hygiene |
| 05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
| 05/04/2010 | CA2455566C (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 05/04/2010 | CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
| 05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
| 05/04/2010 | CA2427385C Nutritional composition for an immune condition |
| 05/04/2010 | CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same |
| 05/04/2010 | CA2417646C Topical gel delivery system |
| 05/04/2010 | CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/04/2010 | CA2347981C Process for the manufacturing of alkaline salts of substituted sulphinyl compounds and products prepared thereby |
| 05/04/2010 | CA2320467C Cycloalkene derivatives, their production and use |
| 05/04/2010 | CA2312087C Preparation comprising sterically hindered amines for the prevention and treatment of inflammation |
| 05/04/2010 | CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation |
| 05/04/2010 | CA2172398C Methods and products for controlling immune responses in mammals |
| 04/29/2010 | WO2010048559A2 Phenylpyrazole inhibitors of store operated calcium release |
| 04/29/2010 | WO2010048365A2 Therapeutic peptide bioconjugates |
| 04/29/2010 | WO2010048314A1 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS |
| 04/29/2010 | WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 04/29/2010 | WO2010047295A1 Medicine for preventing or treating pain related to herpes zoster |
| 04/29/2010 | WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010046835A1 Crystalline forms of (r) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [z] ylidene] -2- ( [z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
| 04/29/2010 | WO2010046639A1 Fused pyridine derivatives as kinase inhibitors |
| 04/29/2010 | WO2010046273A2 Pyrimidinyl pyridone inhibitors of jnk |
| 04/29/2010 | WO2010045723A1 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent |
| 04/29/2010 | WO2010015929A3 Uses of mesenchymal stem cells |
| 04/29/2010 | WO2010011772A3 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 04/29/2010 | WO2010009091A3 Anti-inflammatory and anti-allergy extracts from nettle |
| 04/29/2010 | WO2010006267A3 Cyclic tetrapeptides |
| 04/29/2010 | WO2010006129A3 2-methylene-(22e)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
| 04/29/2010 | WO2009158719A3 Methods and compositions for treating disorders |
| 04/29/2010 | WO2009152493A9 Use of apolipoproteins to decrease inflammation |
| 04/29/2010 | US20100105953 Human Adam-10 Inhibitors |
| 04/29/2010 | US20100105946 Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol) |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105784 Pharmaceutical Pellets Comprising Modified Starch and Therapeutic Applications Therefor |
| 04/29/2010 | US20100105777 Amide or thioamide derivatives and their use in the treatment of pain |
| 04/29/2010 | US20100105767 Compounds, compositions and methods |
| 04/29/2010 | US20100105740 vanilloid receptor antagonists such as 1-[4-(2-hydroxyethoxy)-2-bromo-5-methoxybenzyl]-3-[4-(trifluoromethyl)-benzyl]urea, useful for the treatment of neuropathic pain, urogenital disorders, hemorrhoids, inflammation, post-operative pain, respiratory and gastrointerstinal disorders |
| 04/29/2010 | US20100105729 Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agents |
| 04/29/2010 | US20100105723 5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS |
| 04/29/2010 | US20100105708 Pyrrolopyrimidines for pharmaceutical compositions |
| 04/29/2010 | US20100105686 Phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105677 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 04/29/2010 | US20100105664 Organic compounds |
| 04/29/2010 | US20100105658 Aza-bridged-ring compound |
| 04/29/2010 | US20100105642 Novel compounds 409 |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100104670 Use of chitosans for the treatment of nail inflammatory diseases |
| 04/29/2010 | US20100104657 Pharmaceutical composition comprising a reduced concentration of cholesterol |
| 04/29/2010 | US20100104651 Pharmaceutical Compositions Containing Diacerein |
| 04/29/2010 | US20100104648 Treatment of inflammatory and/or bacterial conditions with particles of microstructure |
| 04/29/2010 | US20100104582 CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts |
| 04/29/2010 | US20100104581 Methods for Diagnosing and Treating Graft Rejection and Inflammatory Conditions |
| 04/29/2010 | US20100104573 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104559 Us cip-compositions and methods for modulating responses mediated or associated with btla activity |
| 04/29/2010 | US20100104516 Use of flagellin to prevent and treat gram negative bacterial infection |
| 04/29/2010 | US20100104511 Methods and compositions using chelator-antibody conjugates |
| 04/29/2010 | DE4035442B4 Arzneimittel enthaltend als Wirkstoff R-α-Liponsäure A medicament comprising as an active ingredient R-α-lipoic acid |
| 04/29/2010 | DE102009004436A1 Verwendung einer Tirucallensäure, einer Lupansäure oder einer Robursäure als Arzneimittel Using a Tirucallensäure, a Lupansäure or Robur acid as a drug |
| 04/29/2010 | CA2778170A1 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent |
| 04/29/2010 | CA2741313A1 Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors |
| 04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740313A1 Crystalline forms of (r) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [z] ylidene] -2- ( [z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
| 04/29/2010 | CA2739882A1 Pharmaceutical composition improving intestinal absorption |
| 04/29/2010 | CA2734037A1 Pyrimidinyl pyridone inhibitors of jnk |
| 04/28/2010 | EP2180053A2 Wisp polypeptides and therapeutical applications thereof |
| 04/28/2010 | EP2179999A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 04/28/2010 | EP2179737A2 Modulating responsiveness to steroids |
| 04/28/2010 | EP2178888A1 Proteasome inhibitors |
| 04/28/2010 | EP2178874A1 Heterocyclic compounds useful as mk2 inhibitors |
| 04/28/2010 | EP2178873A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |